Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Leases (2019 - 2025)

Fortress Biotech (FBIO) has 7 years of Leases data on record, last reported at $12.3 million in Q3 2025.

  • For Q3 2025, Leases fell 12.94% year-over-year to $12.3 million; the TTM value through Sep 2025 reached $12.3 million, down 12.94%, while the annual FY2024 figure was $13.9 million, 18.42% down from the prior year.
  • Leases reached $12.3 million in Q3 2025 per FBIO's latest filing, down from $12.8 million in the prior quarter.
  • Across five years, Leases topped out at $20.1 million in Q1 2021 and bottomed at $12.3 million in Q3 2025.
  • Average Leases over 5 years is $17.1 million, with a median of $18.0 million recorded in 2023.
  • Peak YoY movement for Leases: rose 5.19% in 2022, then decreased 19.19% in 2025.
  • A 5-year view of Leases shows it stood at $19.0 million in 2021, then grew by 5.19% to $20.0 million in 2022, then decreased by 15.01% to $17.0 million in 2023, then fell by 18.42% to $13.9 million in 2024, then dropped by 11.11% to $12.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $12.3 million in Q3 2025, $12.8 million in Q2 2025, and $13.3 million in Q1 2025.